Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439082
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-27
Brief Title:
A Study to Investigate the Efficacy and Safety of Crizanlizumab 5 mgkg Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises SPARKLE
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sickle Cell Disease |
Keywords:
| Name | View |
|---|---|
| sickle-cell crisis | View |
| Sickle Cell Disease | View |
| SCD | View |
| SEG101 | View |
| Crizanlizumab | View |
| Hydroxyurea Hydroxycarbamide Therapy | View |
| Vaso-Occlusive Crises | View |
| Sickle Cell Anemia | View |
| blood disorders | View |
| hemoglobin | View |
| red blood cells | View |
| sickle-like shape | View |
| mutation in hemoglobin gene | View |
| sickle-cell trait | View |